BioNTech (Germany) Performance

22UA Stock  EUR 93.80  1.60  1.74%   
BioNTech has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.18, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BioNTech are expected to decrease at a much lower rate. During the bear market, BioNTech is likely to outperform the market. BioNTech SE right now shows a risk of 2.8%. Please confirm BioNTech SE downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if BioNTech SE will be following its price patterns.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, BioNTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Ex Dividend Date
2022-06-02
1
Is BioNTech SE Depositary Receipt stock a top pick in earnings season - July 2025 Closing Moves Stepwise Entry and Exit Trade Signals - newser.com
11/18/2025
2
BioNTech Advances with CureVac Exchange Offer Approval - TipRanks
11/26/2025
3
Analysts Offer Insights on Healthcare Companies Nano-X Imaging , Edgewise Therapeutics and BioNTech SE - The Globe and Mail
12/05/2025
4
BMO Capital Keeps Their Buy Rating on BioNTech SE - The Globe and Mail
12/11/2025
5
Aug Selloffs What margin trends mean for BioNTech SE Depositary Receipt stock - July 2025 Snapshot Capital Efficient Trade Techniques - moha.gov.vn
01/13/2026
6
What to Expect From Pfizers Non-Oncology Business in Q4 - Zacks Investment Research
01/19/2026
7
BioNTech Soars 11.8 percent Is Further Upside Left in the Stock - Nasdaq
01/22/2026
8
BioNTech SEs Price Is Right But Growth Is Lacking After Shares Rocket 26 percent - simplywall.st
01/28/2026
9
Leerink downgrades BioNTech to market perform after 24 percent share rally - Investing.com
02/02/2026
  

BioNTech Relative Risk vs. Return Landscape

If you would invest  9,210  in BioNTech SE on November 8, 2025 and sell it today you would earn a total of  170.00  from holding BioNTech SE or generate 1.85% return on investment over 90 days. BioNTech SE is generating 0.0693% of daily returns assuming 2.8043% volatility of returns over the 90 days investment horizon. Simply put, 25% of all stocks have less volatile historical return distribution than BioNTech, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon BioNTech is expected to generate 3.66 times more return on investment than the market. However, the company is 3.66 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

BioNTech Target Price Odds to finish over Current Price

The tendency of BioNTech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 93.80 90 days 93.80 
about 17.53
Based on a normal probability distribution, the odds of BioNTech to move above the current price in 90 days from now is about 17.53 (This BioNTech SE probability density function shows the probability of BioNTech Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon BioNTech SE has a beta of -0.18. This suggests as returns on the benchmark increase, returns on holding BioNTech are expected to decrease at a much lower rate. During a bear market, however, BioNTech SE is likely to outperform the market. Additionally BioNTech SE has an alpha of 0.1055, implying that it can generate a 0.11 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   BioNTech Price Density   
       Price  

Predictive Modules for BioNTech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioNTech SE. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
91.2694.0696.86
Details
Intrinsic
Valuation
LowRealHigh
74.4077.20103.18
Details
Naive
Forecast
LowNextHigh
84.2387.0489.84
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BioNTech. Your research has to be compared to or analyzed against BioNTech's peers to derive any actionable benefits. When done correctly, BioNTech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BioNTech SE.

BioNTech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BioNTech is not an exception. The market had few large corrections towards the BioNTech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioNTech SE, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioNTech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.11
β
Beta against Dow Jones-0.18
σ
Overall volatility
6.16
Ir
Information ratio 0.02

BioNTech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioNTech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioNTech SE can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
The company reported the revenue of 2.75 B. Net Loss for the year was (665.3 M) with profit before overhead, payroll, taxes, and interest of 2.6 B.
About 57.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: Leerink downgrades BioNTech to market perform after 24 percent share rally - Investing.com

BioNTech Fundamentals Growth

BioNTech Stock prices reflect investors' perceptions of the future prospects and financial health of BioNTech, and BioNTech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioNTech Stock performance.

About BioNTech Performance

By analyzing BioNTech's fundamental ratios, stakeholders can gain valuable insights into BioNTech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioNTech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioNTech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 171.97  180.57 
Return On Tangible Assets(0.03)(0.03)
Return On Capital Employed(0.06)(0.06)
Return On Assets(0.03)(0.03)
Return On Equity(0.04)(0.04)

Things to note about BioNTech SE performance evaluation

Checking the ongoing alerts about BioNTech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioNTech SE help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the revenue of 2.75 B. Net Loss for the year was (665.3 M) with profit before overhead, payroll, taxes, and interest of 2.6 B.
About 57.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: Leerink downgrades BioNTech to market perform after 24 percent share rally - Investing.com
Evaluating BioNTech's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BioNTech's stock performance include:
  • Analyzing BioNTech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioNTech's stock is overvalued or undervalued compared to its peers.
  • Examining BioNTech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BioNTech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioNTech's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of BioNTech's stock. These opinions can provide insight into BioNTech's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BioNTech's stock performance is not an exact science, and many factors can impact BioNTech's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for BioNTech Stock analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing